COMMUNIQUÉS West-GlobeNewswire

Hua Medicine completes patient enrollment for Phase III monotherapy trial of dorzagliatin
01/03/2019
SHANGHAI, China, March 01, 2019 (GLOBE NEWSWIRE) -- Hua Medicine (HKEX: 2552), a Shanghai-based drug development company focused on developing a global first-in-class oral drug for the treatment of Type 2 diabetes, [...]
Bone Therapeutics announces 2018 full year results
01/03/2019
Regulated Information Significant progress across all areas of the business Positioned to move the clinical pipeline into late-stage development Proprietary, optimised commercial production process fully operational [...]
Bone Therapeutics publie ses résultats annuels 2018
01/03/2019
Information réglementée Avancées significatives dans tous les secteurs d’activité En position pour faire passer le portefeuille clinique à un stade de développement avancé Procédés de production commerciale brevetés, [...]
CannaPharmaRx Announces the Acquisition of a Minority Interest in GN Ventures, a Canadian Cannabis Producer, and the Appointment of Dominic Colvin as CEO and Chairman of the Board
01/03/2019
Company Continues to acquire Cannabis Grow Capacity in Canada IRVINE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CannaPharmaRx, Inc. (OTC Pink Sheets: “CPMD”) announced today it has completed the acquisition of a [...]
Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2018
01/03/2019
TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) (‘Revive’ or the ‘Company’) , a specialty cannabis company focused on the research, development and [...]
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia
01/03/2019
COPENHAGEN, Denmark, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today [...]
Extendicare Announces 2018 Year End Results and Leadership Changes
01/03/2019
MARKHAM, Ontario, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the fourth quarter and year ended December 31, 2018. Results are presented in [...]
Management Cease Trade Order Update
01/03/2019
HALIFAX, Nova Scotia, Feb. 28, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/03/2019
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on February 28, 2019, that were previously [...]
MediciNova Announces the Publication of Results of the Animal Model Study of MN‑166 (ibudilast) in Glioblastoma in Scientific Reports
01/03/2019
LA JOLLA, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Lexicon Pharmaceuticals Announces Poster Presentations at the 16th Annual ENETS Conference
28/02/2019
THE WOODLANDS, Texas, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that data from two posters highlighting XERMELO ® (telotristat ethyl) will be presented at the [...]
Assembly Biosciences Reports Fourth Quarter and Year End 2018 Financial Results
28/02/2019
SAN FRANCISCO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
IMV Inc. dépose un supplément de prospectus provisoire dans le cadre d’un projet d’appel public à l’épargne visant des actions ordinaires
28/02/2019
DARTHMOUTH, Nouvelle-Écosse, 28 févr. 2019 (GLOBE NEWSWIRE) -- IMV Inc. (« IMV » ou la « société ») (NASDAQ : IMV; TSX : IMV), société de recherche clinique en immuno‑oncologie, dépose aujourd’hui un supplément de [...]
IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
28/02/2019
DARTMOUTH, Nova Scotia, Feb. 28, 2019 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (NASDAQ: IMV; TSX: IMV), a clinical-stage immuno-oncology corporation, has today filed a preliminary prospectus supplement [...]
Emergent BioSolutions Awarded U.S. Department of State Contract to Supply Medical Countermeasures For Chemical Warfare Agents
28/02/2019
GAITHERSBURG, Md., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has signed an indefinite-delivery, indefinite-quantity (IDIQ) contract with the U.S. Department of [...]
Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2018 Operating Results
28/02/2019
2018 Revenue of $204.3 million, growth of 53%; 4Q 2018 Revenue of $57.3 million, growth of 32% Provides initial 2019 financial outlook MOORESTOWN, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“ [...]
The Board of Directors of Xbrane has resolved on a fully guaranteed rights issue of up to approximately SEK 60 million
28/02/2019
Press release 28 February 2019 The Board of Directors in Xbrane Biopharma AB (publ) ("Xbrane" or the "Company") has today, pursuant to the authorization granted by the annual general meeting on 24 May 2018, resolved on [...]
Coherus BioSciences Reports Fourth Quarter and Full Year 2018 Financial Results
28/02/2019
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today reviewed corporate events and reported financial results for the quarter and full year ended December 31, 2018. [...]
Geron to Announce Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
28/02/2019
MENLO PARK, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that it will release its fourth quarter and full year 2018 financial results after the market closes on Thursday, [...]

Pages